Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMV574J)

Drug Name

CSL312 Drug Info

Synonyms

Garadacimab

Indication

Disease Entry	ICD 11	Status	REF
Hereditary angioedema	4A00.14	Phase 3	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Coagulation factor XII (F12)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ION547	DMVNKNJ	Thrombosis	DB61-GB90	Phase 1	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	ClinicalTrials.gov (NCT04656418) CSL312 (Garadacimab) in the Prevention of Hereditary Angioedema Attacks. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of CSL Behring.
3	ClinicalTrials.gov (NCT04934891) A Double-Blind, Placebo-Controlled, Dose-Escalation Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ION547 Administered Subcutaneously to Healthy Subjects. U.S.National Institutes of Health.